1. The microcide tenofovir does not inhibit nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine samples.
   Wood BJ, Rizzo-Price P, Holden J, Hardick A, Quinn TC, Gaydos CA.
   J Clin Microbiol 2008;46:763-65.

summary               

2. Chlamydia trachomatis RNA in the environment: is there potential for false-positive nucleic acid amplifications test results?
   Meader E, Waters J, Sillis M.
   Sex Transm Infect 2008;84:107-10.

summary               

3. Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma.
   Guo M, Gong Y, Deavers M, Silva EG, Jan YJ, Cogdell DE, Luthra R, Lin E, Lai HC, Zhang W, Sneige N.
   J Clin Microbiol 2008;46:274-80.

summary               

4. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study.
   Castle PE, Gravitt PE, Solomon D, Wheeler CM, Schiffman M.
   J Clin Microbiol 2008;46:109-17.

summary               

5. High occurrence of a new variant of Chlamydia trachomatis escaping diagnostic tests among STI clinic patients in Stockholm, Sweden.
   Marions L, Rotzen-Ostlund M, Grillner L, Edgardh K, Tiveljung-Lindell A, Wikstrom A, Lidbrink P.
   Sexually Transmitted Disease 2008;35:61-64.

summary               

6. Human papillomavirus (HPV) in atypical squamous cervical cytology: the Invader HPV test as a new screening assay.
   Wong AK, Chan R C-K, Nichols WS, Bose S.
   Journal of Clinical Microbiology 2008;46:869-75.

summary               

7. Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers.
   Schmitt M, Dondog B, Waterboer T, Pawlita M.
   Journal of Clinical Microbiololgy 2008;46:1050-59.

summary               

8. Detection of human papillomavirus from self-collected vaginal samples of women in Chiang Mai, Thailand.
   Wongworapat K, Keawvichit R, Sirirojn B, Dokuta S, Ruangyuttikarn C, Sriplienchan S, Sontirat A, Kla KT, Gravitt PE, Celentano DD.
   Sexually Transmitted Disease 2008;35:172-73.

summary               

9. Screening for Chlamydia trachomatis at the time of routine Pap smear in general practice: a cluster randomized controlled trial.
   Bowden FJ, Currie MJ, Toyne H, McGuiness C, Lim LL, Butler JR, Glasgow NJ.
   The Medical Journal of Australia 2008:188:76-80.

summary               

10. Genotyping of Chlamydia trachomatis by microsphere suspension array.
    Huang C-T, Wong W-W, Li L-H, Chiang C-C, Chen B-D, Li S-Y.
    Journal of Clinical Microbiology 2008;46:1126-28.

summary               

11. Direct identification of chlamydiae from clinical samples using a DNA microarray assay—A validation study.
    Borel N, Kempf E, Hotzel H, Schubert E, Torgerson P, Slickers P, Ehricht R, Tasara T, Pospischil A, Sachse K.
    Molecular and Cellular Probes 2008;22:55-64.

summary               

12. Comparison of microscopy, culture and in-house PCR and NASBA assays for diagnosis of Neisseria gonorrhoeae in Russia.
    Shipitsyna E, Guschin A, Maximova A, Tseslyuk M, Savicheva A, Sokolovsky E, Shipulin G, Domeika M, Unemo M.
    AMPIS 2008;116:133-38.

summary               

13. PCR testing for Treponema pallidum in paraffin-embedded skin biopsy specimens: test design and impact on the diagnosis of syphilis.
    Behrhof W, Springer E, Brauninger W, Kirkpatrick CJ, Weber A.
    Journal of Clinical Pathology 2008;61:390-95.

summary               

14. Rapid, sensitive, and specific lateral-flow immunochromatographic point-of-care device for detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in serum and whole blood.
    Laderman, EI, Whitworth E, Dumaual E, Jones M, Hudak A, Hogrefe W, Carney J, Groen J.
    Clinical and Vaccine Immunology 2008;15:159-63.

summary               

15. Accuracy of herpes simplex virus detection in liquid-based (SurePath) Papanicolaou tests: a comparison with polymerase chain reaction.
    Aslan DL, Pambuccian SE, Prekker FL, Schacker TW, Southern P, Savik K, McKeon D, Gulbahce HE.
    Diagnostic Cytopathology 2008;36:94-103.

summary               

16. Use of commercial enzyme immunoassays to detect antibodies to the herpes simplex virus type 2 glycoprotein G in a low-risk population in Hanoi, Vietnam.
    Ngo TD, Laeyendecker O, La H, Hogrefe W, Morrow RA, Quinn TC.
    Clinical and Vaccine Immunology 2008;15:382-84.

summary               

17. Evaluation of risk score algorithms for detection of chlamydial and gonococcal infection in an emergency department setting.
    Al-Tayyib AA, Miller WC, Rogers SM, Leone PA, Gesink DC, Ford CA, Rothman RE.
    Academic Emergency Medical Journal 2008;15:126-35.

summary               

18. Syndromic approach to sexually transmitted infections in Tunisian women: bacteriological validation.
    Zribi M, Mansour KB, Abid F, Masmoudi A, Fendri C.
    International Journal of STD & AIDS 2008;19:112-14.

summary               

19. A comparative study of three different PCR assays for detection of Mycoplasma genitalium in urogenital specimens from men and women.
    Edberg A, Jurstrand M, Johansson E, Wikander E, Höög A, Ahlqvist T, Falk L, Jensen JS, Fredlund H.
    Journal of Medical Microbiology 2008;57:304-9.

summary               

20. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance.
    Duncan L, Jacob, Hubbard E.
    Cancer Cytopathology 2008;114:34-48.

summary               

21. Comparison of p16INK4a and Hybrid Capture 2 human papillomavirus testing as adjunctive tests in liquid-based gynecologic SurePath preparations.
    Nassar A, O’Reilly K, Cohen C, Siddiqui MT.
    Diagnostic Cytopathology 2008;36:142-48.

summary               

22. Comparison of the AMPLICOR human papillomavirus test and the Hybrid Capture 2 assay for detection of high-risk human papillomavirus in women with abnormal PAP smear.
    De Francesco MA, Gargiulo F, Schreiber C, Ciravolo G, Salinaro F, Manca M.
    Journal of Virological Methods 2008;147:10-17.

summary               

23. Anal human papillomavirus testing with Digene’s Hybrid Capture 2 using two different sampling methods.
    Roka F, Roka J, Trost A, Schalk H, Zagler C, Kirnbauer R, Salat A.
    Diseases of the Colon & Rectum 2008;51:62-66.

summary               

24. Automated extraction and quantification of oncogenic HPV genotypes from cervical samples by resl-time PCR-based system.
    Broccolo F, Cocuzza CE.
    Journal of Virological Methods 2008;148:48-57.

summary               

25. Comparison of AMPLICOR and Hybrid Capture II assays for high risk HPV detection in normal and abnormal liquid-based cytology: Use of INNO-LiPA genotyping assay to screen the discordant results.
    Mo LZ, Monnier-Benoit S, Kantelip B, Petitjean A, Riethmuller D, Prétet JL, Mougin C.
    Journal of Clinical Virology 2008;41:104-10.

summary               

26. Exploring “best practice” for nucleic acid detection of Neisseria gonorrhoeae.
    Whiley DM, Garland SM, Harnett G, Lum G, Smith DW, Tabrizi SN, Sloots TP, Tapsall JW.
    Sexual Health 2008;5:17-23.

summary               

27. From the NIH: Proceeding of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections.
    Hobbs MM, Van der Pol B, Totten P, Gaydos CA, Wald A, Warren T, Winer RL, Cook RL, Deal CD, Rogers ME, Schachter J, Holmes KK, Martin DH.
    Sexually Transmitted Disease 2008;35:8-13.

summary